Search

Your search keyword '"Chang Wook, Kim"' showing total 138 results

Search Constraints

Start Over You searched for: Author "Chang Wook, Kim" Remove constraint Author: "Chang Wook, Kim" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
138 results on '"Chang Wook, Kim"'

Search Results

1. Incorporating ALBI Grade with Geriatric Nutritional Risk Index Enhances Hepatocellular Carcinoma Risk Stratification

2. Effect of Biliary Drainage on the Prognosis of Patients with Hepatocellular Carcinoma and Bile Duct Invasion

3. The insert and revolve technique: a novel approach for inserting cages during unilateral biportal endoscopic assisted fusion surgery for effective spinal alignment restoration

4. Analysis of Immune-Related Adverse Events of Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma: A Multicentre Cohort Study

5. Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study

6. Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study

7. Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease

8. Comprehensive transcriptomic analysis and meta-analysis identify therapeutic effects of N-acetylcysteine in nonalcoholic fatty liver disease

9. Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C

10. Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding

11. Surgical Impact on Global Sagittal Alignment and Health-Related Quality of Life Following Cervical Kyphosis Correction Surgery: Systematic Review

12. Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response

13. Differential liver function at cessation of atezolizumabbevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study.

14. Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them

15. Hepatogastric fistula as a rare complication of pyogenic liver abscess

16. A Decade-old Change in the Screening Rate for Hepatocellular Carcinoma Among a Hepatitis B Virus-infected Population in Korea

17. Systematic Review of Reciprocal Changes after Spinal Reconstruction Surgery : Do Not Miss the Forest for the Trees

18. 1852. Recurrent Bacteremia after Endoscopic Injection of N-butyl-2-cyanoacrylate for Gastric Variceal Bleeding

20. Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C

21. Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients

22. Association between Posttreatment Serum Platelet-to-Lymphocyte Ratio and Distant Metastases in Patients with Hepatocellular Carcinoma Receiving Curative Radiation Therapy

23. Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease

24. Hepatitis C virus: virology and life cycle

25. Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition.

26. Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding

27. Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response

28. Lipiodol Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

29. Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease

30. Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study

31. The Role of Urinary N-Acetyl-β-d-glucosaminidase in Cirrhotic Patients with Acute Kidney Injury: Multicenter, Prospective Cohort Study

32. Long-term Prognosis of Acute-on-Chronic Liver Failure Survivors

33. Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis

34. Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them

35. Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis

36. Surgical Impact on Global Sagittal Alignment and Health-Related Quality of Life Following Cervical Kyphosis Correction Surgery: Systematic Review

38. Community-onset Necrotizing Fasciitis Caused by Extended-spectrum Beta-lactamase-producing Eshcerichia coli

39. Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5′-UTR of TRIM22

40. Hepatogastric fistula as a rare complication of pyogenic liver abscess

41. Recurrent pyogenic liver abscess as a presenting manifestation of colorectal cancer

42. Systematic Review of Reciprocal Changes after Spinal Reconstruction Surgery: Do Not Miss the Forest for the Trees.

43. Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis

44. A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC

45. A Decade-old Change in the Screening Rate for Hepatocellular Carcinoma Among a Hepatitis B Virus-infected Population in Korea

46. Complications Requiring Hospital Admission and Causes of In-Hospital Death over Time in Alcoholic and Nonalcoholic Cirrhosis Patients

47. Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study

48. Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection

49. Cholangiocarcinoma with a paraneoplastic leukemoid reaction mimicking a pyogenic liver abscess

50. Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis

Catalog

Books, media, physical & digital resources